ABSENOR

This brand name is authorized in Finland, Lithuania, Poland

Active ingredients

The drug ABSENOR contains one active pharmaceutical ingredient (API):

UNII 5VOM6GYJ0D - VALPROATE SODIUM

Valproic acid is anti-convulsant. The most likely mode of action for valproate is potentiation of the inhibitory action of gamma amino butyric acid (GABA) through an action on the further synthesis or further metabolism of GABA.

Read about Valproic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
N03AG01
Valproic acid
N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AG Fatty acid derivatives
Discover more medicines within N03AG01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 007097, 007111, 007134, 106609, 106617, 120535, 469395
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1004788
PL
Rejestru Produktów Leczniczych
Identifier(s): 100168073, 100168989

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈